DENTSPLY SIRONA (NASDAQ:XRAY) Hits New 12-Month Low – What’s Next?

Shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) reached a new 52-week low during mid-day trading on Friday. The company traded as low as $9.35 and last traded at $9.4250, with a volume of 1640398 shares changing hands. The stock had previously closed at $9.53.

Analyst Upgrades and Downgrades

Several analysts have issued reports on XRAY shares. Weiss Ratings restated a “sell (e+)” rating on shares of DENTSPLY SIRONA in a report on Monday, August 3rd. Barrington Research set a $15.00 price objective on shares of DENTSPLY SIRONA in a report on Monday, August 10th. Barclays raised their price objective on shares of DENTSPLY SIRONA from $9.00 to $11.00 and gave the stock an “underweight” rating in a research report on Monday, August 24th. Piper Sandler lifted their target price on shares of DENTSPLY SIRONA from $13.00 to $14.00 and gave the stock a “neutral” rating in a research note on Wednesday, July 29th. Finally, BMO Capital Markets dropped their price target on shares of DENTSPLY SIRONA from $13.00 to $10.00 and set a “market perform” rating for the company in a research note on Thursday, September 17th. Three investment analysts have rated the stock with a Buy rating, nine have issued a Hold rating and three have issued a Sell rating to the company. According to MarketBeat, the stock currently has a consensus rating of “Hold” and an average price target of $13.31.

DENTSPLY SIRONA Price Performance

The company’s 50-day moving average price is $11.62 and its 200-day moving average price is $11.37. The company has a quick ratio of 1.07, a current ratio of 1.63 and a debt-to-equity ratio of 1.48. The firm has a market cap of $1.87 billion, a price-to-earnings ratio of -3.42, a PEG ratio of 1.27 and a beta of 0.84.

DENTSPLY SIRONA (NASDAQ:XRAY) last released its earnings results on Thursday, August 6th. The medical instruments supplier reported $0.52 EPS for the quarter, topping the consensus estimate of $0.35 by $0.17. DENTSPLY SIRONA had a positive return on equity of 20.84% and a negative net margin of 14.99%.The firm had revenue of $898.00 million during the quarter, compared to analysts’ expectations of $889.93 million. During the same period in the previous year, the firm posted $0.52 EPS. DENTSPLY SIRONA’s revenue for the quarter was down 4.1% on a year-over-year basis. DENTSPLY SIRONA has set its FY 2026 guidance at 1.400-1.500 EPS. On average, equities research analysts forecast that DENTSPLY SIRONA Inc. will post 1.4 EPS for the current year.

Hedge Funds Weigh In On DENTSPLY SIRONA

Hedge funds have recently made changes to their positions in the company. Envestnet Portfolio Solutions Inc. increased its position in DENTSPLY SIRONA by 42.6% during the second quarter. Envestnet Portfolio Solutions Inc. now owns 60,828 shares of the medical instruments supplier’s stock worth $645,000 after buying an additional 18,181 shares during the period. Tidal Investments LLC boosted its holdings in shares of DENTSPLY SIRONA by 13.1% in the second quarter. Tidal Investments LLC now owns 371,967 shares of the medical instruments supplier’s stock valued at $3,947,000 after acquiring an additional 43,025 shares during the period. Engineers Gate Manager LP grew its position in shares of DENTSPLY SIRONA by 451.5% during the second quarter. Engineers Gate Manager LP now owns 124,810 shares of the medical instruments supplier’s stock worth $1,324,000 after acquiring an additional 102,179 shares during the last quarter. Integrated Wealth Concepts LLC purchased a new position in shares of DENTSPLY SIRONA during the second quarter worth approximately $791,000. Finally, Allworth Financial LP raised its position in DENTSPLY SIRONA by 163.8% in the 2nd quarter. Allworth Financial LP now owns 4,815 shares of the medical instruments supplier’s stock valued at $51,000 after purchasing an additional 2,990 shares during the last quarter. Hedge funds and other institutional investors own 95.70% of the company’s stock.

About DENTSPLY SIRONA

DENTSPLY SIRONA is a global manufacturer of professional dental products and technologies. The company serves dentists, dental laboratories, and other oral health professionals with solutions spanning preventive, restorative, endodontic, orthodontic, implant, and prosthetic dentistry.

Its portfolio includes dental consumables, equipment and treatment centers, imaging systems, CAD/CAM systems, instruments, dental materials, implants, orthodontic products, and software and digital workflow solutions.